PLAGL1 Antikörper (AA 1-100) (Biotin)

Produktnummer ABIN1389901

Produktdetails anti-PLAGL1 Antikörper (Biotin)

Target: PLAGL1 (Pleiomorphic Adenoma Gene-Like 1 (PLAGL1))

Bindungsspezifität: AA 1-100

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLAGL1 Antikörper ist konjugiert mit Biotin

Applikation: ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Kreuzreaktivität: Maus

Homologie: Human,Rat,Dog,Pig,Zebrafish

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human PLAGL1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu PLAGL1

Target: PLAGL1 (Pleiomorphic Adenoma Gene-Like 1 (PLAGL1))

Andere Bezeichnung: PLAGL1/ZAC1 (PLAGL1 Produkte)

Synonyme: PLAGL1 antikoerper, LOT1 antikoerper, ZAC antikoerper, ZAC1 antikoerper, Lot1 antikoerper, Zac1 antikoerper, PLAG1 like zinc finger 1 antikoerper, uncharacterized LOC100350914 antikoerper, pleiomorphic adenoma gene-like 1 antikoerper, PLAGL1 antikoerper, LOC100350914 antikoerper, Plagl1 antikoerper

Hintergrund:

Synonyms: DKFZp781P1017, Lost on transformation 1, Lost on Transformation, LOT-1, LOT1, MGC126275, MGC126276, PLAG like 1, PLAGL1, PLAL1_HUMAN, Pleiomorphic adenoma gene like 1, Pleiomorphic adenoma gene like protein 1, Pleiomorphic adenoma-like protein 1, Tumor supressor ZAC, ZAC, ZAC tumor supressor, ZAC1, Zinc finger protein PLAGL1.

Background: This gene encodes a C2H2 zinc finger protein with transactivation and DNA-binding activities. It has been shown to have anti-proliferative properties, and thus thought to function as a tumor suppressor. In addition, overexpression of this gene during fetal development is believed to underlie the rare disorder, transient neonatal diabetes mellitus (TNDM). This gene is imprinted, with preferential expression of the paternal allele in many tissues, however, biallelic expression has been noted in peripheral blood leucocytes. A recent study reports that tissue-specific imprinting results from variable utilization of monoallelic and biallelic promoters. Many transcript variants differing in the 5' UTR and encoding two different isoforms, have been found for this gene. [provided by RefSeq, Oct 2010].